Profil
Gerard Garramone currently works at Mirimus, Inc., as Operations Director.
Postes actifs de Gerard Garramone
Sociétés | Poste | Début |
---|---|---|
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Mirimus, Inc.
Mirimus, Inc. Medical SpecialtiesHealth Technology Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010. | Health Technology |